Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinations. [PDF]
Sader HS +5 more
europepmc +1 more source
Use of Aztreonam-Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing <i>Enterobacter cloacae</i>. [PDF]
Keck JM +4 more
europepmc +1 more source
<i>In vitro</i> activity of aztreonam-avibactam and distribution of carbapenemase genes in ceftazidime-avibactam-resistant carbapenem-resistant Enterobacterales: data from the global Antimicrobial Testing Leadership and Surveillance, 2019-2023. [PDF]
Lee Y-L +5 more
europepmc +1 more source
Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023). [PDF]
Sader HS +4 more
europepmc +1 more source
Practical Application of Aztreonam-Avibactam as a Treatment Strategy for Ambler Class B Metallo-β-Lactamase Producing Enterobacteriaceae. [PDF]
Wong DW.
europepmc +1 more source

